Psychedelic Bulletin #142: Terran’s IP Portfolio; AMA Advocates Against Non-Medical Psychedelics;...

COMPASS Pathways plc to announce second quarter 2023 financial results on...

Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

PT427 – The Philosophy of Law Enforcement, The Criminalization of Self-Directed...

Revive Therapeutics Announces Filing of Patent for Bucillamine in the Treatment...

MIND CURE ANNOUNCES LNG ENERGY GROUP CREDIT AGREEMENT IN THE AMOUNT...

Small Pharma Reports Fiscal First Quarter 2024 Highlights

Optimi Health Announces Receipt of Purported Termination Notice

Navigating Psychedelics: Vital Tools for Risk Reduction and Integration – Denver

Kiyumí Psilocybin Retreat & Vital Training: Netherlands

Load more